phrykt

Eli Lilly (LLY) share buybacks: $4.1B

Eli Lilly spent $4.1B buying back its own shares in the year ended Dec 31, 2025, up 64.3% from $2.5B a year earlier.

From Eli Lilly's filings with the SEC · Read the filing · LLY stock page

Eli Lilly share buybacks by year

$1.2B2021$1.5B2022$750M2023$2.5B2024$4.1B2025

#50 of 1,890 US companies by share buybacks · See the full ranking

Year endedShare buybacksChange
Dec 31, 2025$4.1B+64%
Dec 31, 2024$2.5B+233%
Dec 31, 2023$750M-50%
Dec 31, 2022$1.5B+20%
Dec 31, 2021$1.2B–

Share buybacks of similar companies

Companies in the same industry as Eli Lilly, by SEC industry code, with the closest share buybacks. Each name opens the same page for that company.

CompanyShare buybacks, latest yearYear ended
Johnson & Johnson$6BDec 28, 2025
Merck$5.1BDec 31, 2025
Eli Lilly$4.1BDec 31, 2025
Regeneron Pharmaceuticals$3.4BDec 31, 2025
Zoetis$3.2BDec 31, 2025
Vertex Pharmaceuticals Inc / Ma$2BDec 31, 2025
Royalty Pharma$1.2BDec 31, 2025

Questions and answers

What is Eli Lilly's share buybacks?

Eli Lilly spent $4.1B buying back its own shares in the year ended Dec 31, 2025, up 64.3% from $2.5B a year earlier.

Numbers as reported in Eli Lilly's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology